Trials / Completed
CompletedNCT00262717
Can Resistance Enhance Selection of Treatment? (CREST)
A Randomised Comparator Study to Assess the Relative Efficacy of Genotypic Versus Virtual Phenotypic Resistance Tests in Treatment Experienced Patients With HIV Infection for Whom a Change in Therapy is Indicated
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 338 (actual)
- Sponsor
- Kirby Institute · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare two commercially available platforms for assessment of HIV drug resistance to determine which provides superior virological results. We hypothesise that one test will be significantly superior to the other.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood test: genotype testing |
Timeline
- Start date
- 2001-03-01
- Primary completion
- 2006-01-30
- Completion
- 2006-07-31
- First posted
- 2005-12-07
- Last updated
- 2025-06-26
Locations
19 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00262717. Inclusion in this directory is not an endorsement.